According to the U.S. FDA, medical device design controls “control the design process to assure that devices meet user needs, intended uses, and specified requirements.” 

For medical device manufacturers, it is critical to have robust design controls as they help ensure quality, safety, and effectiveness of the end product. Design controls are particularly important for Class II and Class III medical devices while most Class I devices are exempt. 

For one, in the United States, 21 CFR 820.30 mandates that a robust design control system include human factors analysis under design input, design verification, and design validation.

Technical documentation for design controls includes summary reports, material certificates, plans, protocols, and reports. 

According to one FDA investigator, if there are concerns about a manufacturer’s quality system, the investigator may take a closer look at areas such as design controls. 

Related: There were 1,272 FDA 483 observations for design controls involving medical device GMP operations over the past ten years. Contact Redica to see how we can help you stay on top of the latest GMP inspection trends to make your inspection preparation easier.

Design Controls
Redica Systems Enforcement Analytics | Design Control 483 Observations

Design Control Warning Letter Citations

For examples of FDA warning letter citations involving medical device design controls, check out the following from over the years.

Additional Design Control Resources

What is Your Human Factors Engineering Strategy?

Impact of the EU MDR on Combination Product Sale and Registration in the EU

Process Capability in Focus in FDA Device Inspections

Week of February 24th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Warning Letters Week of 3/1/2020: Device Design Controls

FDA Warning Letters Week of 4/6/2020: Devices, BIMO

Get a Demo

We’ll can show you insights into any of your key suppliers, FDA investigators, inspection trends, and much more.

Request a Demo